Synbio Tech (ROCO:1295) Total Liabilities: NT$1,915 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1295 Synbio Tech Inc ROCO:1295
61 GF Score
Price NT$45.50
GF Value NT$82.72
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Synbio Tech Total Liabilities?

Synbio Tech ROCO:1295 -1.40% 61 Total Liabilities is NT$1,915 Mil as of Jun. 2026. GuruFocus rates ROCO:1295 with a GF Score™ of 61/100 and a GF Value™ of NT$82.72 (Possible Value Trap). The stock has 12 warning signs investors should review.

Synbio Tech's Total Liabilities for the quarter that ended in Jun. 2026 was NT$1,915 Mil.

Synbio Tech's quarterly Total Liabilities increased from Dec. 2025 (NT$1,755.10 Mil) to Mar. 2026 (NT$2,042.38 Mil) but then declined from Mar. 2026 (NT$2,042.38 Mil) to Jun. 2026 (NT$1,915.34 Mil).

Synbio Tech's annual Total Liabilities increased from Dec. 2023 (NT$943.27 Mil) to Dec. 2024 (NT$1,265.08 Mil) and increased from Dec. 2024 (NT$1,265.08 Mil) to Dec. 2025 (NT$1,755.10 Mil).

Synbio Tech Total Liabilities Historical Data

* Premium members only.

The historical data trend for Synbio Tech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio Tech Total Liabilities Chart

Synbio Tech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 669.93 779.07 943.27 1,265.08 1,755.10

Synbio Tech Quarterly Data
Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,527.64 1,581.87 1,755.10 2,042.38 1,915.34
ROCO:1295
61GF Score
Synbio Tech Inc ROCO:1295
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synbio Tech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Synbio Tech's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=639.769+(1048.146+67.182
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,755

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3085.253-1330.156
=1,755

Synbio Tech's Total Liabilities for the quarter that ended in Jun. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=836.734+(1010.425+68.185
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1,915

Total Liabilities=Total Assets (Q: Jun. 2026 )-Total Equity (Q: Jun. 2026 )
=3226.02-1310.676
=1,915

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of NT$1,915 Mil mean?
Synbio Tech (ROCO:1295) has a Total Liabilities of NT$1,915 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Synbio Tech and its competitors.
Is Synbio Tech's Total Liabilities too high?
Synbio Tech's current Total Liabilities is NT$1,915 Mil. Overall, Synbio Tech has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Total Liabilities compare to VRTX and REGN?
Synbio Tech's Total Liabilities of NT$1,915 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Synbio Tech and its competitors. Synbio Tech's current Total Liabilities is NT$1,915 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Based on GuruFocus' analysis, Synbio Tech (ROCO:1295) is currently considered Possible Value Trap. The stock's GF Value™ is NT$82.72, compared to a current price of NT$45.50 — trading 45% below its estimated fair value. The current Total Liabilities is NT$1,915 Mil. Synbio Tech's overall GF Score™ is 61/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Total Liabilities is NT$1,915 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synbio Tech (ROCO:1295) Overvalued in 2026?

Based on GuruFocus' analysis, Synbio Tech stock appears to be undervalued. The current stock price of NT$45.50 is trading 45% below its estimated GF Value™ of NT$82.72. GuruFocus considers Synbio Tech to be Possible Value Trap.

Key valuation signals for ROCO:1295:

  • Total Liabilities: NT$1,915 Mil
  • GF Value™: NT$82.72 vs. price of NT$45.50 (45% below fair value)
  • GF Score™: 61/100 with 12 warning signs

No single metric tells the full story. See the ROCO:1295 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synbio Tech Business Description

Address No.82, Beiling 6th Road, Luzhu District, Kaohsiung, TWN, 821
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
61GF Score

Get the complete analysis for ROCO:1295

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$45.50
Price
NT$82.72
GF Value